Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated the efficacy and safety of ustekinumab in anti-TNF refractory patients with active radiographic axial spondyloarthritis (ankylosing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Axial Spondyloarthritis | Phase 3 | Status: TERMINATED | Results posted: 2018-10-01